by Dr. Michael Garin | Nov 1, 2021 | Eye Care, Eye Conditions, Eye Injury, General Health
It’s been a long day at the home office — as many of us continue to work from home during the pandemic — with several video calls thrown in, to boot. You probably haven’t taken as many breaks from the computer as you should have and the soreness in your neck is now...
by Dr. Michael Garin | Aug 5, 2021 | Eye Care, Eye Conditions, Myopia
If your child has myopia—also known as nearsightedness or shortsightedness—you are not alone. This condition is becoming more and more common. In fact, experts predict it will affect more than 50% of the world’s population by 2050. The good news is that there are now...
by Dr. Michael Garin | Jul 1, 2021 | Eye Conditions, Eye Infections / Disease
Melanoma Skin cancer is the most common kind of cancer in the United States. In fact, it is estimated that one out of seven people in the United States are diagnosed with skin cancer each year. What Causes Skin Cancer? Certain risk factors put you at...
by Dr. Michael Garin | Apr 7, 2021 | Eye Conditions, Eye Infections / Disease
Vitreous hemorrhage has an incidence of seven cases per 100,000, which makes it one of the most common causes of acutely or subacutely decreased vision. Although the diagnosis of vitreous hemorrhage is generally straightforward, management is dictated by uncovering...
by Dr. Michael Garin | Apr 5, 2021 | Eye Conditions, General Health
Dyslexia is a complex condition that affects the way the brain processes and interprets information. Dyslexia can impact reading, writing, and spelling skills. Dyslexia can also cause difficulty with organizational skills, concentration in noisy environments,...
by Dr. Michael Garin | Mar 10, 2021 | Eye Conditions, Eye Infections / Disease
A xanthelasma is a yellowish deposit of fat and cholesterol found under the skin that’s around or on the eyelids. Xanthelasmata are not harmful, nor do they cause any pain, but most people do not care for the appearance of these yellow growths around the eyes and...
